Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.

Shimabukuro, Tom; Nair, Narayan

Shimabukuro, Tom; Nair, Narayan.

Shimabukuro T; Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Nair N; Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland.

JAMA ; 325(8): 780-781, 2021 Feb 23.

Article in English | MEDLINE | ID: covidwho-1125853

Subject(s)

Anaphylaxis/etiology; COVID-19 Vaccines/adverse effects; Hypersensitivity/etiology; Adult; Anaphylaxis/epidemiology; Female; Humans; Hypersensitivity/epidemiology; Male; Middle Aged; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / Hypersensitivity / Anaphylaxis Type of study: Observational study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: JAMA Year: 2021 Document Type: Article Affiliation country: Jama.2021.0600

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google